Klaria Pharma Holding AB (publ.) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.8%.

Top 18 shareholders own 50.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.17%	Kojak Stockholm AB	8,000,000	€550.0k	0%	no data
6.03%	SIX Group Ltd	7,821,307	€537.7k	0%	no data
5.52%	Ålandsbanken Asset Management Ab	7,166,053	€492.6k	0%	0.59%
4.1%	Avanza Fonder AB	5,325,079	€366.1k	0%	no data
3.55%	Skandinaviska Enskilda Banken AB, Private Banking, Investment Banking, and Insurance Arm	4,600,000	€316.2k	0%	0.01%
3.12%	Jack Weil	4,053,785	€278.7k	0%	no data
3.08%	Promenaden Invest AB	4,000,000	€275.0k	0%	no data
3.08%	Djerdu Invest AB	4,000,000	€275.0k	0%	no data
2.93%	Fredrik Hubinette	3,796,375	€261.0k	0%	no data
2.89%	Buntel AB	3,752,120	€257.9k	0%	no data
2.86%	Munkekullen 5 förvaltning AB	3,707,120	€254.9k	0%	no data
2.75%	Gerard Dal	3,563,509	€245.0k	0%	no data
2.74%	Pictet & Cie (Europe) S.A., Asset Management Arm	3,554,413	€244.4k	0%	no data
0.93%	Jesper Wiklund	1,203,654	€82.7k	0%	no data
0.56%	Scott Boyer	731,042	€50.3k	0%	no data
0.019%	Marc Willuhn	25,000	€1.7k	0%	no data
0.0069%	FCG Fonder AB	8,907	€612.0	0%	no data
0.00069%	Hans Olivecrona	890	€61.6	0%	no data